BR9509902A - Fragmentos de anticorpos monoclonais apresentando atividade imunosupressante - Google Patents

Fragmentos de anticorpos monoclonais apresentando atividade imunosupressante

Info

Publication number
BR9509902A
BR9509902A BR9509902A BR9509902A BR9509902A BR 9509902 A BR9509902 A BR 9509902A BR 9509902 A BR9509902 A BR 9509902A BR 9509902 A BR9509902 A BR 9509902A BR 9509902 A BR9509902 A BR 9509902A
Authority
BR
Brazil
Prior art keywords
monoclonal antibody
antibody fragments
immunosuppressive activity
fragments showing
showing immunosuppressive
Prior art date
Application number
BR9509902A
Other languages
English (en)
Inventor
Zoltan Nagy
Damir Vidovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR9509902A publication Critical patent/BR9509902A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2833—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against MHC-molecules, e.g. HLA-molecules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BR9509902A 1994-12-07 1995-11-25 Fragmentos de anticorpos monoclonais apresentando atividade imunosupressante BR9509902A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35091594A 1994-12-07 1994-12-07
PCT/EP1995/004648 WO1996017874A1 (en) 1994-12-07 1995-11-25 Monoclonal antibody fragments having immunosuppressant activity

Publications (1)

Publication Number Publication Date
BR9509902A true BR9509902A (pt) 1997-10-21

Family

ID=23378740

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9509902A BR9509902A (pt) 1994-12-07 1995-11-25 Fragmentos de anticorpos monoclonais apresentando atividade imunosupressante

Country Status (19)

Country Link
EP (1) EP0787151A1 (pt)
JP (1) JP2001506122A (pt)
CN (1) CN1168679A (pt)
AR (1) AR002005A1 (pt)
AU (1) AU4256096A (pt)
BR (1) BR9509902A (pt)
CA (1) CA2206471A1 (pt)
CO (1) CO4480041A1 (pt)
CZ (1) CZ172497A3 (pt)
FI (1) FI972430A7 (pt)
HU (1) HUT77342A (pt)
IL (1) IL116228A0 (pt)
MA (1) MA23739A1 (pt)
NO (1) NO972522L (pt)
PE (1) PE52996A1 (pt)
PL (1) PL320610A1 (pt)
TR (1) TR199501542A2 (pt)
WO (1) WO1996017874A1 (pt)
ZA (1) ZA9510195B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0893507A1 (en) * 1997-07-25 1999-01-27 Institut Gustave Roussy Use of MHC class II ligands (CD4 and LAG-3) as adjuvant for vaccination and of LAG-3 in cancer treatment
AU5588099A (en) 1998-08-28 2000-03-21 Dendreon Corporation Selective apoptosis of neoplastic cells by an hla-dr specific monoclonal antibody
EP1156062A1 (en) * 2000-05-12 2001-11-21 GPC Biotech AG Immunomodulatory human MHC class II antigen-binding peptides/proteins
ATE365749T1 (de) * 2000-05-12 2007-07-15 Gpc Biotech Ag Humane peptide/proteine, die das töten von zellen,einschliesslich lymphoide tumorzellen, herbeiführen oder bewirken
US7521047B2 (en) 2000-05-12 2009-04-21 Gpc Biotech Ag Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells
US20030086929A1 (en) 2001-10-11 2003-05-08 Tso J. Yun Treatment of prostate cancer by inhibitors of ATP synthase
EP1369431A4 (en) 2001-10-15 2005-01-12 Kirin Brewery ANTI-HLA-DR ANTIBODIES
EP1768662A2 (en) 2004-06-24 2007-04-04 Novartis Vaccines and Diagnostics, Inc. Small molecule immunopotentiators and assays for their detection
EP2552483A4 (en) * 2010-04-01 2013-09-25 Immunomedics Inc USE OF ANTIBODIES TO REDUCE THE NUMBER OF CELLS CONTAINING ANTIGENS AND DENDRITIC CELLS
KR102647825B1 (ko) * 2021-07-22 2024-03-14 서울대학교산학협력단 항-hla-dp 단클론 항체 및 이의 용도

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0068790B1 (en) * 1981-06-25 1986-02-26 The Board Of Trustees Of The Leland Stanford Junior University Allele specific immunotherapeutic method and dosage form
JPH05502586A (ja) * 1989-12-27 1993-05-13 セントカー・インコーポレーテツド Ｃｄ４受容体に対するキメラ免疫グロブリン
NZ243706A (en) * 1991-07-25 1994-08-26 Idec Pharma Corp Recombinant monkey antibodies, pharmaceutical compositions

Also Published As

Publication number Publication date
NO972522L (no) 1997-08-06
IL116228A0 (en) 1996-03-31
MX9704225A (es) 1997-09-30
TR199501542A2 (tr) 1996-07-21
FI972430L (fi) 1997-06-06
PL320610A1 (en) 1997-10-13
AR002005A1 (es) 1998-01-07
PE52996A1 (es) 1996-12-12
ZA9510195B (en) 1996-06-07
EP0787151A1 (en) 1997-08-06
CO4480041A1 (es) 1997-07-09
CZ172497A3 (en) 1997-10-15
MA23739A1 (fr) 1996-07-01
WO1996017874A1 (en) 1996-06-13
FI972430A0 (fi) 1997-06-06
FI972430A7 (fi) 1997-06-06
NO972522D0 (no) 1997-06-03
AU4256096A (en) 1996-06-26
CA2206471A1 (en) 1996-06-13
CN1168679A (zh) 1997-12-24
HUT77342A (hu) 1998-03-30
JP2001506122A (ja) 2001-05-15

Similar Documents

Publication Publication Date Title
DK1516629T3 (da) Humaniseret anti-CD-11a antibodies
PT719859E (pt) Anticorpo monoclonal anti-alfa v-integrina
IL128406A0 (en) Monoclonal antibodies
DK145493D0 (da) Antistof
FI965032L (fi) Interleukiini-5-spesifisiä yhdistelmä-vasta-aineita
FI964845L (fi) CD44v6:n vastaiset monoklonaaliset vasta-aineet
EP0870826A4 (en) NEW PROTEINS AND MONOCLONAL ANTIBODIES AGAINST THESE
FI945865L (fi) Glykoprofeiini P:lle kohdistettuja monoklonaalisia vasta-aineita
AU6702998A (en) Anti-alphabeta3 humanized monoclonal antibodies
DE69738312D1 (de) Hepatitis b monoklonale antikörper
FI972430L (fi) Immunosuppressiivista aktiivisuutta sisältäviä monoklonaalisen vasta-aineen fragmentteja
EP0977590A4 (en) HUMAN MONOCLONAL ANTIBODIES
GB9718911D0 (en) Monoclonal antibodies
ZA951113B (en) Tumor assosiated monoclonal antibody 123av16
DE69427850D1 (de) Monoklonaler antikörper gegen mucoglykoprotein
BR9709080A (pt) Anticorpo monoclonal anti-MP52 humano
GB9615027D0 (en) Monoclonal antibodies
HK1001864A (en) Monoclonal antibody fragments having immunosuppressant activity
DE69324928D1 (de) Monoklonaler antikörper
SI0742795T1 (en) Immuno-stimulatory monoclonal antibodies
BR1100555B1 (pt) anticorpos monoclonais humanizados.
ZA954678B (en) Monoclonal antibody against cd44v6
FIU950108U0 (fi) Hopsaettbar katsa

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law